Heartflow, Inc. (Form: 4, Received: 08/22/2025 17:16:31)

FORM 4 ☒ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* HealthCor Partners Management LP	2. Issuer Name and Ticker or Trading Symbol Heartflow, Inc. [ HTFL ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 186 SEVEN FARMS DRIVE, SUITE F	3. Date of Earliest Transaction (MM/DD/YYYY) 8/11/2025
(Street) DANIEL ISLAND, SC 29492	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person
(City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	8/11/2025		C		1,248,939	A	⁽¹⁾	1,248,939	I	By HealthCor Partners Fund, L.P. ⁽²⁾⁽⁹⁾
Common Stock	8/11/2025		C		833,075	A	⁽¹⁾⁽³⁾	833,075	I	By HealthCor Partners Fund II, L.P. ⁽⁴⁾⁽⁹⁾
Common Stock	8/11/2025		C		4,615,542	A	⁽³⁾⁽⁵⁾⁽⁶⁾⁽⁷⁾	4,615,542	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series C Preferred	⁽¹⁾	8/11/2025		C			1,248,939 ⁽¹⁾	⁽¹⁾	⁽¹⁾	Common Stock	1,248,939	⁽¹⁾	0	I	By HealthCor Partners Fund, L.P. ⁽²⁾⁽⁹⁾
Series C Preferred Stock	⁽¹⁾	8/11/2025		C			624,471 ⁽¹⁾	⁽¹⁾	⁽¹⁾	Common Stock	624,471	⁽¹⁾	0	I	By HealthCor Partners Fund II, L.P. ⁽⁴⁾⁽⁹⁾
Series D Preferred	⁽³⁾	8/11/2025		C			1,630,231 ⁽³⁾	⁽³⁾	⁽³⁾	Common Stock	1,630,231	⁽³⁾	0	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾
Series D Preferred	⁽³⁾	8/11/2025		C			208,604 ⁽³⁾	⁽³⁾	⁽³⁾	Common Stock	208,604	⁽³⁾	0	I	By HealthCor Partners Fund II, L.P. ⁽⁴⁾⁽⁹⁾
Series E Preferred Stock	⁽⁵⁾	8/11/2025		C			1,099,378 ⁽⁵⁾	⁽⁵⁾	⁽⁵⁾	Common Stock	1,099,378	⁽⁵⁾	0	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾
Series F Preferred Stock	⁽⁶⁾	8/11/2025		C			1,337,337 ⁽⁶⁾	⁽⁶⁾	⁽⁶⁾	Common Stock	1,337,337	⁽⁶⁾	0	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾
Series F-1 Preferred Stock	⁽⁶⁾	8/11/2025		C			452,528 ⁽⁶⁾	⁽⁶⁾	⁽⁶⁾	Common Stock	452,528	⁽⁶⁾	0	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾
Convertible Promissory Note	$15.2	8/11/2025		C			96,068 ⁽⁷⁾	⁽⁷⁾	⁽⁷⁾	Common Stock	96,068	⁽⁷⁾	0	I	By HCPCIV 1, LLC ⁽⁸⁾⁽⁹⁾

Explanation of Responses:
(1)	Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.
(2)	HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCP Fund may be deemed to be beneficially owned by HealthCor Partners L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. Each of HCPLP and HCPGP hereby disclaims any beneficial ownership of shares held by HCP Fund except to the extent of any pecuniary interest therein
(3)	Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.
(4)	HealthCor Partners Fund II, L.P. ("HCPII Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of HCP2LP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein
(5)	Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.
(6)	Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported on Table II herein on an as-converted basis.
(7)	Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II herein on an as-converted basis.
(8)	HCPCIV 1, LLC ("HCPCIV") is a private investment limited liability company which is the direct beneficial owner of the securities reported herein. The shares held by HCPCIV may be determined to be beneficially owned by HCP2LP, its managing member, and by HCPGP. Each of HCP2LP and HCPGP hereby disclaims any beneficial ownership of shares held by HCPCOV except to the extent of any pecuniary interest therein.
(9)	HealthCor Partners Management, L.P. is the investment manager for each of HCP Fund, HCPH Fund, and HCPCIV and has voting and investment discretion with respect to such entities' securities reported herein. HealthCor Partners Management, L.P. hereby disclaims any beneficial ownership of shares held by HCP Fund, HCPH Fund, and HCPCIV except to the extent of any pecuiary interest therein.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
HealthCor Partners Management LP 186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 29492		X
HealthCor Partners GP, LLC 186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 29492		X
HealthCor Partners Fund LP 186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 29492		X
HealthCor Partners LP 1186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 24492		X
HealthCor Partners Fund II, L.P. 186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 24492		X
HealthCor Partners II, L.P. 186 SEVEN FARMS DRIVE, SUITE F DANIEL ISLAND, SC 24492		X
HCPCIV 1, LLC 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK, NY 10019		X

Signatures
HealthCor Partners Management, L.P., by: HealthCor Partners GP, LLC, general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HealthCor Partners Fund, L.P., by: HealthCor Partners, L.P., general partner, by HealthCor Partners GP, LLC, its general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HealthCor Partners, L.P., by: HealthCor Partners GP, LLC, general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HealthCor Partners GP, LLC, by: /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HealthCor Partners Fund II, L.P., by: HealthCor Partners II, L.P., general partner, by HealthCor Partners GP, LLC, its general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HealthCor Partners II, L.P., by: HealthCor Partners GP, LLC, general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date
HCPCIV 1, LLC, by HealthCor Partners II, L.P., managing member, by HealthCor Partners GP, LLC, its general partner, by /s/ Jeffrey C. Lightcap, Senior Managing Director		8/22/2025
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

POWER OF ATTORNEY

Know all by these presents
that each of the undersigned
hereby individually constitutes
and appoints John Doherty
the undersigned's true and
lawful attorney-in-fact, to:

(1) execute for and on behalf of the undersigned a Form ID application, and any amendments thereto, to be filed with the Securities and Exchange Commission to obtain or update EDGAR codes for the undersigned;

(2) execute for and on behalf of the undersigned Forms 3, 4, and 5 and Schedules 13D or 13G, as appropriate, and any amendments thereto (collectively, "Reports"), with respect to his securities ownership of CareView Communications, Inc. (the "Company"), in accordance with Section 13(d) and/or Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Report and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents execute by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

Each of the undersigned hereby
individually grants to such attorney-
in-fact full power and authority to do
and perform any and every act and
thing whatsoever requisite,
necessary, or proper to be done
in the exercise of any of the
rights and powers herein granted,
as fully to all intents and
purposes as the undersigned might
or could do if personally present,
with full power of substitution or
revocation, hereby ratifying and
confirming all that such attorney-
in-fact, or such attorney-in-fact's
substitute or substitutes, shall
lawfully do or cause to be done by
virtue of this power of attorney
and the rights and powers herein
granted. Each of the undersigned
hereby individually acknowledges that
the foregoing attorney-in-fact, in
serving in such capacity at the request
of the undersigned, is not assuming,
nor is the Company assuming, any of
the undersigned's responsibilities
to comply with Section 13(d) or 16 of
the Securities Exchange Act of 1934.

This Power of Attorney shall remain
in full force and effect until the
undersigned are no longer required to
file Reports with respect to such
undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, each of the
undersigned has caused this
Power of Attorney to be
executed as of this 4th day
of October 2021.

/s/ Jeffrey C. Lightcap

/s/ Arthur Cohen

/s/ Joseph Healy

Exhibit 99.1

1. HealthCor Management, L.P.
55 Hudson Yards, 28th Fl., New York, NY 10001;

2. HealthCor Associates, LLC
55 Hudson Yards, 28th Fl., New York, NY 10001;

3. HealthCor Hybrid Offshore Master Fund, L.P.
55 Hudson Yards, 28th Fl., New York, NY 10001;

4. HealthCor Hybrid Offshore GP, LLC
55 Hudson Yards, 28th Fl., New York, NY 10001;

5. HealthCor Group, LLC
55 Hudson Yards, 28th Fl., New York, NY 10001;

6. HealthCor Partners Management, L.P.
55 Hudson Yards, 28th Fl., New York, NY 10001;

7. HealthCor Partners Management GP, LLC 55 Hudson Yards, 28th Fl., New York, NY 10001;

8. HealthCor Partners Fund, L.P.
55 Hudson Yards, 28th Fl., New York, NY 10001;

9. HealthCor Partners, L.P.
55 Hudson Yards, 28th Fl., New York, NY 10001;

10. HealthCor Partners GP, LLC
55 Hudson Yards, 28th Fl., New York, NY 10001;

11. Jeffrey C. Lightcap
55 Hudson Yards, 28th Fl., New York, NY 10001;

12. Arthur Cohen
12 South Main St., Suite 203, Norwalk, CT 06854;

13. Joseph Healey
55 Hudson Yards, 28th Fl., New York, NY 10001;